Author:
Agrawal Meetu,Garg Ravin J.,Cortes Jorge,Quintás-Cardama Alfonso
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Oncology,Hematology
Reference60 articles.
1. Quintás-Cardama A, Cortes J.: Molecular biology of bcr-abl1-positive chronic myeloid leukemia. Blood 2009, 113:1619–1630.
2. Buchdunger E, Zimmermann J, Mett H, et al.: Inhibition of the Abl protein-tyrosine kinase in vitro and in vivo by a 2-phenylaminopyrimidine derivative. Cancer Res 1996, 56:100–104.
3. Druker BJ, Tamura S, Buchdunger E, et al.: Effects of a selective inhibitor of the Abl tyrosine kinase on the growth of Bcr-Abl positive cells. Nature Med 1996, 2:561–566.
4. O’Brien SG, Guilhot F, Larson RA, et al.: Imatinib compared with interferon and low dose cytarabine for newly diagnosed chronic phase chronic myeloid leukemia. N Engl J Med 2003, 348:994–1004.
5. Druker BJ, Guilhot F, O’Brien SG, et al.: Five-year follow up of patients receiving imatinib for chronic myeloid leukemia. N Engl J Med 2006, 355:2408–2417.
Cited by
54 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献